Plasma Aβ as a biomarker for predicting Aβ-PET status in Alzheimer's disease：a systematic review with meta-analysis.

J Neurol Neurosurg Psychiatry · 2022 · PMC9016262 · PMID 35241627

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

quite significantp<0.0001actually significant

The overall effect was also quite significant (p<0.0001), which indicated that plasma Aβ42:Aβ40 ratio had the ability to be a biomarker for distinguishing people with PET (+) and PET (−) as well.

also in 5,705 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.